Literature DB >> 15363961

Adenosine A1 receptors modulate the anxiolytic-like effect of ethanol in the elevated plus-maze in mice.

Rui D S Prediger1, Luciano C Batista, Reinaldo N Takahashi.   

Abstract

The anxiolytic property of ethanol is generally accepted to be an important motivational factor for its consumption and the development of alcohol dependence. Recent studies suggest that adenosine receptors mediate important actions of ethanol, such as motor incoordination and hypnotic effects. In addition, several lines of evidence support the involvement of adenosine in anxiety. The aim of the present study was to evaluate the role of adenosine receptors in the anxiolytic-like effect of ethanol in mice. The effects of acute administration of the adenosine receptor antagonists caffeine (nonselective), 8-cyclopentyl-1,3-dipropylxanthine (DPCPX, adenosine A1 receptor antagonist) and 4-(2-[7-amino-2-[2-furyl][1,2,4]triazolo-[2,3-a][1,3,5]triazin-5-yl-amino]ethyl)phenol (ZM241385, adenosine A(2A) receptor antagonist), together with the adenosine A1 receptor agonist 2-chloro-N6-cyclopentyladenosine (CCPA), and their interaction with ethanol in the elevated plus-maze test in mice were studied. The highest doses of caffeine (30.0 mg/kg, i.p.) and DPCPX (6.0 mg/kg, i.p.) produced an anxiogenic-like effect, while CCPA administration (0.25 mg/kg, i.p.) showed an anxiolytic-like activity. The prior administration of "non-anxiogenic" doses of caffeine (10.0 mg/kg, i.p.) and DPCPX (3.0 mg/kg, i.p.), but not ZM241385 (1.0 mg/kg, i.p.), significantly reduced the anxiolytic-like effect of ethanol (1.2 g/kg, i.p.). Moreover, anxiolytic-like response was observed by the co-administration of "non-anxiolytic" doses of CCPA (0.125 mg/kg) and ethanol (0.6 g/kg). These results reinforce the involvement of adenosine in anxiety and suggest that the activation of adenosine A1 receptors, but not adenosine A(2A) receptors, mediate the anxiolytic-like effect induced by ethanol in mice.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15363961     DOI: 10.1016/j.ejphar.2004.07.106

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  26 in total

1.  Very low concentrations of ethanol suppress excitatory synaptic transmission in rat visual cortex.

Authors:  Lucas Luong; Nicholas M Bannon; Andrew Redenti; Marina Chistiakova; Maxim Volgushev
Journal:  Eur J Neurosci       Date:  2017-03-27       Impact factor: 3.386

Review 2.  Alcohol and Caffeine: The Perfect Storm.

Authors:  Sergi Ferré; Mary Claire O'Brien
Journal:  J Caffeine Res       Date:  2011-09

Review 3.  The Impact of Caffeine on the Behavioral Effects of Ethanol Related to Abuse and Addiction: A Review of Animal Studies.

Authors:  Laura López-Cruz; John D Salamone; Mercè Correa
Journal:  J Caffeine Res       Date:  2013-03

Review 4.  Neuroadaptations in adenosine receptor signaling following long-term ethanol exposure and withdrawal.

Authors:  Tracy R Butler; Mark A Prendergast
Journal:  Alcohol Clin Exp Res       Date:  2011-07-18       Impact factor: 3.455

5.  Nicotine antagonizes caffeine- but not pentylenetetrazole-induced anxiogenic effect in mice.

Authors:  Hakan Kayir; I Tayfun Uzbay
Journal:  Psychopharmacology (Berl)       Date:  2005-07-01       Impact factor: 4.530

6.  Presynaptic adenosine A₁ receptors modulate excitatory transmission in the rat basolateral amygdala.

Authors:  Andrew R Rau; Olusegun J Ariwodola; Jeff L Weiner
Journal:  Neuropharmacology       Date:  2013-11-06       Impact factor: 5.250

7.  Guanosine Anxiolytic-Like Effect Involves Adenosinergic and Glutamatergic Neurotransmitter Systems.

Authors:  Roberto Farina Almeida; Daniel Diniz Comasseto; Denise Barbosa Ramos; Gisele Hansel; Eduardo R Zimmer; Samanta Oliveira Loureiro; Marcelo Ganzella; Diogo Onofre Souza
Journal:  Mol Neurobiol       Date:  2016-01-07       Impact factor: 5.590

8.  Sex differences in caffeine neurotoxicity following chronic ethanol exposure and withdrawal.

Authors:  Tracy R Butler; Katherine J Smith; Jennifer N Berry; Lynda J Sharrett-Field; Mark A Prendergast
Journal:  Alcohol Alcohol       Date:  2009-09-16       Impact factor: 2.826

9.  Modelling anxiety in humans for drug development.

Authors:  Martin Siepmann; Peter Joraschky
Journal:  Curr Neuropharmacol       Date:  2007-03       Impact factor: 7.363

10.  Tianeptine: an antidepressant with memory-protective properties.

Authors:  Phillip R Zoladz; Collin R Park; Carmen Muñoz; Monika Fleshner; David M Diamond
Journal:  Curr Neuropharmacol       Date:  2008-12       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.